Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: Study Protocol Clinical Trial (SPIRIT Compliant)

BACKGROUND: Congenital cytomegalovirus (CMV) disease, a common mother-to-child infection, can lead to neurological sequelae. Some clinical trials have shown that oral valganciclovir (VGCV) can improve hearing and neurodevelopmental impairment in infants with congenital CMV disease. However, VGCV has...

Descripción completa

Detalles Bibliográficos
Autores principales: Morioka, Ichiro, Kakei, Yasumasa, Omori, Takashi, Nozu, Kandai, Fujioka, Kazumichi, Yoshikawa, Tetsushi, Moriuchi, Hiroyuki, Ito, Yoshinori, Oka, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
6200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220768/
https://www.ncbi.nlm.nih.gov/pubmed/32332615
http://dx.doi.org/10.1097/MD.0000000000019765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220768/
https://www.ncbi.nlm.nih.gov/pubmed/32332615
http://dx.doi.org/10.1097/MD.0000000000019765

Ejemplares similares